Pharmaceuticals in Denmark

Date: April 30, 2014
Pages: 32
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Brief Review
Delivery: E-mail Delivery (PDF)
ID: P5CFDEC0445EN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Denmark
Pharmaceuticals in Denmark industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market. Essential resource for top-line data and analysis covering the Denmark pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Highlights
  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2013 annual average exchange rates.
  • The Danish pharmaceuticals market had total revenues of $3.0bn in 2013, representing a compound annual growth rate (CAGR) of 2.5% between 2009 and 2013.
  • The performance of the market is forecast to accelerate, with an anticipated CAGR of 3.6% for the five-year period 2013 - 2018, which is expected to drive the market to a value of $3.6bn by the end of 2018.
  • Pricing pressures borne out by price-cap and price reduction agreements have had a limited effect on the Danish market because they are restricted to hospital medicines and thus do not affect community pharmacies in the primary health care sector.
Features

Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Denmark

Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Denmark

Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance

Add weight to presentations and pitches by understanding the future growth prospects of the Denmark pharmaceuticals market with five year forecasts

Macroeconomic indicators provide insight into general trends within the Denmark economy

Key Questions Answered
  • What was the size of the Denmark pharmaceuticals market by value in 2013?
  • What will be the size of the Denmark pharmaceuticals market in 2018?
  • What factors are affecting the strength of competition in the Denmark pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in Denmark's pharmaceuticals market?
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
GlaxoSmithKline Plc
Orifarm A/S
Pfizer Inc.
Macroeconomic Indicators
Country Data
Appendix
Methodology
Industry associations
Related MarketLine research

LIST OF TABLES

Table 1: Denmark pharmaceuticals market value: $ billion, 2009–13
Table 2: Denmark pharmaceuticals market geography segmentation: $ billion, 2013
Table 3: Denmark pharmaceuticals market share: % share, by value, 2013
Table 4: Denmark pharmaceuticals market value forecast: $ billion, 2013–18
Table 5: GlaxoSmithKline Plc: key facts
Table 6: GlaxoSmithKline Plc: key financials ($)
Table 7: GlaxoSmithKline Plc: key financials (£)
Table 8: GlaxoSmithKline Plc: key financial ratios
Table 9: Orifarm A/S: key facts
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: key financials ($)
Table 12: Pfizer Inc.: key financial ratios
Table 13: Denmark size of population (million), 2009–13
Table 14: Denmark gdp (constant 2000 prices, $ billion), 2009–13
Table 15: Denmark gdp (current prices, $ billion), 2009–13
Table 16: Denmark inflation, 2009–13
Table 17: Denmark consumer price index (absolute), 2009–13
Table 18: Denmark exchange rate, 2009–13

LIST OF FIGURES

Figure 1: Denmark pharmaceuticals market value: $ billion, 2009–13
Figure 2: Denmark pharmaceuticals market geography segmentation: % share, by value, 2013
Figure 3: Denmark pharmaceuticals market share: % share, by value, 2013
Figure 4: Denmark pharmaceuticals market value forecast: $ billion, 2013–18
Figure 5: Forces driving competition in the pharmaceuticals market in Denmark, 2013
Figure 6: Drivers of buyer power in the pharmaceuticals market in Denmark, 2013
Figure 7: Drivers of supplier power in the pharmaceuticals market in Denmark, 2013
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Denmark, 2013
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Denmark, 2013
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Denmark, 2013
Figure 11: GlaxoSmithKline Plc: revenues & profitability
Figure 12: GlaxoSmithKline Plc: assets & liabilities
Figure 13: Pfizer Inc.: revenues & profitability
Figure 14: Pfizer Inc.: assets & liabilities
Skip to top


Pharmaceuticals Global Industry Almanac_2016 US$ 2,995.00 Oct, 2016 · 477 pages

Ask Your Question

Pharmaceuticals in Denmark
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: